通过基于多lncRNA表达的风险评分和整合ISUP分级的名图来预测前列腺癌的进展
Sabrina Ledesma-Bazan1,2, Florencia Cascardo1,2, Juan Bizzotto1,2,3
1Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Departamento de Química Biológica, Laboratorio de Inflamación y Cáncer, C1428EGA, CABA, Buenos Aires, Argentina.
Non-coding RNA research
|April 5, 2024
概括
这项研究确定了7个关键的长非编码RNA (lncRNAs),可以显著预测前列腺癌的进展. 将这些lncRNA与临床数据相结合,为前列腺癌患者的个性化风险评估创造了一个强大的工具.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 由于疾病的异质性和缺乏特定的生物标志物,前列腺癌的预后具有挑战性.
- 整合基因组,转录组和临床病理学数据对于改善临床实践至关重要.
研究的目的:
- 开发一种包含长非编码RNA (lncRNA) 表达和前列腺癌进展临床病理数据的预测模型.
- 确定与前列腺癌患者无进展生存相关的特定lncRNAs.
主要方法:
- 来自5个公共数据集 (n=178) 的RNA-seq数据的生物信息学分析,跨越各种前列腺癌阶段.
- 使用多变量生存分析识别差异表达的lncRNA和与进展时间的关联.
- 开发一个多lncRNA评分和一个结合的风险评分/nomogram集成lncRNA数据和ISUP组.
主要成果:
- 鉴定了30种差异表达的lncRNA,其中7种与进展时间有显著的关联.
- 多个lncRNA得分表明,在得分高的患者中,进展的风险增加了4倍.
- 综合风险评分,包括ISUP组,显示高风险患者的进展风险增加了8倍.
结论:
- 开发的多lncRNA评分和名图有效预测前列腺癌进展风险.
- 整合lncRNA表达和临床病理特征有助于量身定制的风险评估和治疗策略.
- 这种方法可以改善前列腺癌管理的临床决策.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
01:21Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345